Salvinorin A

N/A

Report date: 2024/02/01 20:01:00
NME

Base Information

Drug NameSalvinorin A
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKappa opioid receptor agonists
TargetsKappa opioid receptor
Therapy Area/IndicationsVasospasm, Intracranial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Pennsylvania
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNeurokappa TherapeuticsYale UniversityJohns Hopkins University +[4] 
Active IndicationsN/A
Inactive IndicationsVasospasm, Intracranial

Other Information

ATC CodeN/A
Related LinksN/A